Moderna Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Good morning, everyone. My name is Gena Wang. I'm SMID cap biotech analyst at Barclays. Welcome to our second virtual global health care conference. First, I wish everyone stay healthy, and I would like to thank all the participants, investors, companies and also especially our event team and the corporate access team, who made this virtual health care conference possible.
With that, it's my great pleasure to introduce Steve Hoge, the President of Moderna. Steve? So maybe I will hand over to you to give a brief overview of the company, and then we will go to a Q&A session.
Terrific. Thank you, Gena, and thank you for having us and for this opportunity. What I'd like to do maybe just to open up is provide a bit of an overview of Moderna more broadly, not just COVID and all of our efforts. Although I expect we'll have a robust conversation about our efforts against COVID-19 as a part of the Q&A.
So as many know, but maybe may
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |